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ABSTRACT
Introduction: Hypoglycemia (Hypo) is the
most common side effect of insulin therapy in
people with type 1 diabetes (T1D). Over time,
patients with T1D become unaware of signs and
symptoms of Hypo. Hypo unawareness leads to
morbidity and mortality. Diabetes alert dogs
(DADs) represent a unique way to help patients
with Hypo unawareness. Our group has
previously presented data in abstract form
which demonstrates the sensitivity and
specificity of DADS. The purpose of our
current study is to expand evaluation of DAD
sensitivity and specificity using a method that
reduces the possibility of trainer bias.
Methods: We evaluated 6 dogs aging 1–10 years
old who had received an average of 6 months of
training for Hypo alert using positive training
methods. Perspiration samples were collected
from patients during Hypo (BG 46–65 mg/dL)
and normoglycemia (BG 85–136 mg/dl) and
were used in training. These samples were
placed in glass vials which were then placed
into 7 steel cans (1 Hypo, 2 normal, 4 blank)
randomly placed by roll of a dice. The dogs
alerted by either sitting in front of, or pushing,
the can containing the Hypo sample. Dogs were
rewarded for appropriate recognition of the
Hypo samples using a food treat via a remote
control dispenser. The results were videotaped
and statistically evaluated for sensitivity
(proportion of lows correctly alerted, ‘‘true
positive rate’’) and specificity (proportion of
blanks ? normal samples not alerted, ‘‘true
negative rate’’) calculated after pooling data
across all trials for all dogs.
Results: All DADs displayed statistically
significant (p value \0.05) greater sensitivity
(min 50.0%–max 87.5%) to detect the Hypo
sample than the expected random correct alert
of 14%. Specificity ranged from a min of 89.6%
to a max of 97.9% (expected rate is not defined
in this scenario).
Conclusions: Our results suggest that properly
trained DADs can successfully recognize and
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alert to Hypo in an in vitro setting using smell
alone.
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INTRODUCTION
Hypoglycemia (Hypo) is the most common side
effect of insulin therapy, particularly with
intensive insulin management which is the
recommended regimen for patients with type
1 diabetes (T1D) [1]. Episodes are often
distressing and carry the risk of serious
neurological and cardiovascular sequelae [1].
Hypo is especially dangerous in patients who
have lost the early warning symptoms of falling
blood glucose levels (Hypo unawareness) [1].
Episodes of Hypo occurring at night have been
cited as a cause of death [2]; Hypo is one of the
most feared complications of diabetes. Fear of
Hypo can result in patients not taking adequate
insulin [3]. Ever-expanding technology,
including more accurate glucometers and
continuous glucose monitors [4, 5], has helped
patients proactively monitor for Hypo, yet there
is always a need for additional methods for use
in different situations to help patients prevent
serious Hypo,
Dogs represent a unique alerting system for
Hypo. One published report indicates that over
one-third of dogs living with a diabetic, even
dogs not specifically trained for the task,
demonstrate behavioral changes during their
owner’s Hypo episodes [6]. Dogs which are
specifically trained to alert for Hypo are called
diabetes alert dogs (DADs). There has been
multiple anecdotal or case reports [7–11]
describing the benefits of these trained dogs as
an alerting system. Our group previously
presented an abstract [7] which described the
clinical impact of DADs by presenting results of
a proprietary questionnaire given to patients
before and after DAD placement. Despite these
reports, it is clear that more robust
demonstration of success is needed before
DADs can be validated as a potential tool to
aid patients with diabetes. The purpose of our
current study was to test the hypothesis that
dogs can be successfully trained to alert to Hypo
samples collected from people with T1D.
METHODS
Selection of Dogs
Our group utilizes dogs from shelters to train as
DADs and all of them were trained for
obedience for later certification for public
access. Dogs which were trained for this study
were selected by the Medical Mutts Director and
Trainer (JC) based on personality traits
identified as compatible for service dog
training [12, 13]. Some of these traits included
sociability, trainability, adaptability and
confidence. The dogs were also selected based
on their physical aptitude for the job, such as
size, health and shape of their noses. Selected
dogs were 9–18 months of age to assure
sufficient maturity for assessing temperament.
Collection of Patient Samples Used
for Training
Samples were collected from 4 patients with
T1D and were used for up to 2 weeks for
ongoing training. Patients were instructed on
collection of samples by personal instruction
with endocrinologist (DSH). They were also
provided a written instruction sheet describing
sample collection, as well as a YouTube link
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reviewing the procedure. Patients were
instructed to use a gauze pad (2 9 2, Johnson
and Johnson, New Brunswick, NJ, USA) to wipe
their forehead and back of the neck, then to
place the pad into a zip-locked bag (Ziplock
brand, SC Johnson, Racine, WI, USA).
Immediately after placing the sample into the
bag, the patient also blew an exhaled breath
into the bag before sealing it. Each bag
contained a label on which patients wrote
their initials, date/time of collection and their
corresponding blood sugar value. Patients were
instructed to deliver samples to a central site
within in 48 h of collection. The samples were
stored in the freezer (Temperature 0 F, -18 C)
until use.
Patients were instructed to collect samples
during Hypo and normoglycemia. The
reference ranges for Hypo- and
normo-glycemia were given according to
American Diabetes Association guidelines [14]
(Hypo:\70 mg/dl; normo: fasting\100 mg/dl;
pre-prandial 80–130 mg/dl; post-prandial
\180 mg/dl). Patients measured their blood
glucose levels using their home glucometers
and were trained on the use and quality
control of their glucometers by their health
care professionals. Patients were instructed to
collect the Hypo samples only if they felt able
to do so and to collect the sample within
5 min of the occurrence, but only after
confirmation of the hypoglycemic event as
measured by their glucometer. Once the Hypo
sample was collected, patients were instructed
to wait a minimum of 8 h before collecting a
sample for normoglycemia. They were also
instructed not to wait longer than 24 h to
collect the normoglycemic samples. Samples
used in our study were collected according to
an Institutional Review Board approved
protocol.
Training
The DADs used for this study were trained using
positive reinforcement methods [12, 13], using
a clicker (marker) paired with a reward (food
treat). Coercion-based methods were avoided so
as not to increase the chance of the dog
developing anxiety, fears, or resistance to
certain situations or to certain tasks [15]. Dogs
were equipped with flat quick release collars and
a front clip harness.
The dogs were trained for good behavior
according to established methods [16]. This
training included how not to be bothered by
sudden noises, children running by, or by
people trying to interact with them. They were
taught to lie quietly under the table when at the
restaurant or at the office, to walk within a foot
of the handler without pulling on the leash and
to ignore people or other animals. During their
training, they learned 30 commands, including
sit, down, stay, under (to lie down under the
table), hurry (to potty on cue in designated
areas), come, stand, touch, bed (go to the dog’s
sleeping place), heel, side, jump, off, crawl, find
help, get/give (retrieval of different items such
as a phone, glucose tablets or a small bag), etc.
Specific training for Hypo alert was done in
three phases. The first phase was designed to
teach the dog to recognize the Hypo samples by
introducing them to the skin and breath
samples collected from patients (as described
above). During this initial training, the samples
were placed in a glass vial. The dog was taught
to put its nose on the vial and immediately alert
by sitting. If the dog alerted correctly to the
Hypo sample, it was rewarded with a food treat
(positive reinforcement). Once the behavior of
touching and sitting was automatic, in other
words, no longer required prompting from the
trainer, the second phase of training was begun.
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In the second phase, the vial containing the
Hypo sample was placed in a one gallon-sized
steel can. The dog was expected to go to the can,
followed by smelling the vial then sitting. Once
the dog sat appropriately in front of the can
containing the Hypo sample, a food reward was
given. Once this task worked repeatedly for the
single sample, additional cans containing
identical vials were gradually introduced. Each
of these additional cans and vials contained
either blank or normoglycemia samples. The
additional samples were from the same person as
the Hypo sample. The introduction of each
additional sample was dependent on the
improvement of the dog’s ability to understand
the discrimination task (i.e., repeatedly alert to
the Hypo sample, but not to the other sample(s).
In the third phase of training, the glass vials
containing samples were placed on a person.
The sitting alert was replaced by teaching the
dog to alert by poke of the nose on the person’s
body. (Specific to this study: some of the dogs
participating in this study were already in their
final stages of training, and were conditioned to
poke a person when detecting Hypo. Thus, it
was decided that said dogs would use their nose
to push the can to indicate which can contained
the Hypo sample, instead of sitting, to avoid
potential confusion and set-backs in their
training). During all training, the appropriate
alert was rewarded by the trainer using a food
treat and praise.
Once the dog was trained competently to
alert to Hypo at all three phases of the training;
the dog was introduced to samples from
additional patients and the process of training
continued until the dog was competently able
to distinguish Hypo samples from
normoglycemia samples from multiple
patients. Once the dog was fully trained to
recognize Hypo from multiple patients, able to
localize to the body and provide the trained
alert, the dog was then called a DAD and at that
point could be considered for placement with a
diabetic person. For our study, we used fully
trained DADs.
Testing Environment and Protocol
We created a specific testing environment for
purposes of this study (Fig. 1). During testing,
the dogs were placed in a closed room, separate
from any human, which contained the samples
as described below. The dogs were rewarded for
successful identification of the Hypo sample
with a treat from an automatic dispenser
remotely activated by the trainer: the Pet
Tutor (Indianapolis, IN, USA). This measure
removed the need for a person in the test room,
thus also decreasing possible sources of
distraction, or information, to the dog.
The cans in the room were arranged as
follows. One Hypo sample was placed in one
steel can, normoglycemia samples were placed
in two cans, and four cans contained a blank
gauze pad. The cans were placed on the floor in
a semi-circle one foot apart. The order of
placement was determined by roll of the dice.
The semi-circle of cans was placed facing the
entrance of the room 15 feet from room entry.
The Pet Tutor was set on the floor, facing the
cans, at an approximate distance of 8 feet. The
dogs were led into the test room, on their own,
and the door was closed behind them.
Monitoring of their behavior was done by the
experimenter with the use of a video camera
and reinforcement of the accurate alert was
provided by remote dispense of a treat from the
Pet Tutor. The dogs were called out of the test
room soon after being rewarded. The results
were videotaped using a video camera placed in
the closed room.
Dogs were tested in random fashion and
testing occurred for a maximum of 1 min per
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trial. Each dog was tested eight times (4 patient
samples 9 2 replicated trials). Dogs were given a
2-h break after the first four tests.
Statistical evaluation of this study
The videotaped recordings of the dog’s
detection of the Hypo sample were reviewed
and scored by the statistician (W.A.). Sensitivity
(proportion of lows correctly alerted, ‘‘True
positive rate’’) and specificity (proportion of
non-low samples: blanks or normal samples not
alerted, ‘‘True negative rate’’) calculated after
pooling data across all trials for all dogs.
Specificity was determined as the proportion
of non-low samples (blanks or normal samples
not alerted, the ‘‘true negative’’ rate).
Each trial began with randomized placement
of samples in each of the cans. For the second trial
(a replicate), random placement again occurred.
Scoring rules for trial outcomes can be found in
Table 1. Statistical results were calculated using
JMP 12 software (SAS Inc., Carey, NC, USA) and
reported similarly to results published from
cancer-detecting dogs [17].
RESULTS
For this analysis, six dogs were evaluated and
each dog was studied eight times. Table 2
presents the breed/mix of dogs, gender and age.
One of seven sample cups (14.29%)
contained the Hypo sample. Therefore, the
expected random chance alert sensitivity level
was 14%. All DADS displayed a statistically
significantly greater sensitivity (50.0%–87.5%)













Fig. 1 Room layout for testing DADs
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Specificity ranged from 50.0% to 89.6%.
Overall, the best four dogs performed at 87.5%
sensitivity and 97.9% specificity. The dog with
the poorest performance displayed 50.0%
sensitivity and 89.6% specificity. Results are
presented in Table 3.
DISCUSSION
Our results demonstrate that DADs are able to
identify Hypo and be trained to alert to its
presence. The results reported here take canine
glucose sensing to a new level of
sophistication. Using the Pet Tutor, a
remote-controlled treat-dispensing device
which removed human interaction during the
testing, we have clearly been able to
demonstrate that DADs sense Hypo accurately
due to smell alone. Once DADs are placed with
their owner/patient, it also likely DADs will
cue to certain behavioral clues exhibited by the
patient and these cues would also likely serve
to help the DAD properly alert the owner of
impending Hypo.
The results from our current trial are better
than those we presented in a previous abstract
[7]. Potential reasons for the better performance
by these DADs include: (1) One dog
participating in the trial presented in our prior
abstract was new to training, and young. Her
poor performance had a lot of influence on the
overall results from our prior trial of four dogs,
(2) in our current study, we used containers
with materials which do not collect previous
scent and never re-used a Hypo container for
any other scent (blank or normal), (3) instead of
using a Lazy Susan device, which provides less
area to spread out the containers, we used
random placement where the containers were
more spaced out, thus minimizing potential
overlap of the scent plume, (4) in the current
Table 1 Scoring rules for DAD actions within a trial
Scenario Action by DAD Low sample Non-low sample
(blank, normal)
1 1st alert True positive (TP) False positive (FP)
2 Subsequent alertsa False negative (FN) (since not 1st alert) False positive (FP)
3 No alert (within time) False negative (FN) True negative (TN)
4 No alert timeout (no action by DAD) False negative (FN) True negative (TN)
In our recent study (#3) there were no scenarios for #4, i.e., all dogs gave an alert before the end of time (60 s)
DADs diabetes alert dogs
a For ‘‘subsequent alerts’’ within the same trial this scoring is conservative and may be thought of as a penalty for guessing.
For example, if the dog did alert on the low but only after alerting on a non-low the result is scored as miss or false negative.
12 of 60 alerts or 20% were subsequent alerts and varied by dog
Sensitivity ¼ 100% True PositivesTrue PositivesþFalseNegatives Specificity ¼ 100% TrueNegativesTrueNegativesþFalse Positives
Table 2 BREED/MIX of DADs used in the
representative results trial
Breed of dog Age Gender
Labrador retriever 2 Male
Flat coated retriever 2 Female
Siberian husky mix 1.5 Female
Spaniel mix 1 Male
German shepherd 10 Female
Labrador retriever 2 female
DADs diabetes alert dogs
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study, the dogs had a short break after four
trials, allowing clearance of their olfactory
senses (5) in our current study, we used The
Pet Tutor which allowed the dogs to be enclosed
in a room without a person, thus minimizing
human interaction/distraction. The trial
reported in our previous abstract took place
with handlers in the same room as the dog.
Despite our current trial setup, we
acknowledge that there are limitations to our
study. The use of the Pet Tutor and placing the
dogs inside a closed room for the study
minimized cues from the trainer; however, we
cannot completely assure no clues could have
been sensed by the dog. Another problem is our
use of a small number of dogs. Larger studies are
needed. Finally, anytime an animal is used for
study, there may be differences in performance
due to inherent differences between animals
studied, and those in a normal daily
environment. Not all dogs will perform as well
as these. Our study dogs received consistent
instruction from a highly skilled trainer. DADs
placed in a home environment need to have
consistent reinforcement from their owners to
remain accurate. Thus, careful selection of the
patient and ongoing patient instruction are
necessary for success.
Our study reinforces previous reports [6–11]
which document the ability of dogs to
recognize Hypo. However, several reports have
refuted the ability of service dogs [18], including
DADs [19]. A recent study by Dehlinger et al.
[20] reported that dogs were unable to recognize
Hypo. Several problems with the study limit its
usefulness. In Dehlinger’s trial, three DADs
which had been previously trained and placed
with T1D patients were removed from their
homes for an in vitro study in which they were
asked to alert to Hypo samples from three T1D
patients ‘‘unfamiliar’’ to the DAD. Thus, the
DADs were placed in an unfamiliar setting and
given Hypo samples not belonging to their
owner, despite their ongoing work with one
person. Although trainers routinely begin
training with multiple Hypo samples, once the
DAD is ready to be placed with a specific
patient, the training samples only come from
the future owner. This ensures that the DAD
works for his/her person and helps ensure the
best service for the particular owner. It is well
known that dogs can be affected by changes in
Table 3 Sensitivity and speciﬁcity for Six DADs evaluated for representative results












Carlie 56 1 1 47 7 87.5 97.9 7.25E-06 Not deﬁned
Isabella 56 4 5 43 4 50 89.6 1.47E-02 Not deﬁned
Jake 56 1 1 47 7 87.5 97.9 7.25E-06 Not deﬁned
Juniper 56 1 1 47 7 87.5 97.9 7.25E-06 Not deﬁned
Nala 56 1 1 47 7 87.5 97.9 7.25E-06 Not deﬁned
Roscoe 56 3 3 44 6 66.7 93.6 0.000155928 Not deﬁned
Total 11 12 275 38 77.6 95.8 1.98E-23 Not deﬁned
Assumes binomial distribution prob success = 0.14 #Trials = 8 per dog
DADs diabetes alert dogs, FN false negative, FP false positive, TN true negative, TP true positive
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their environment, by differences in training
commands or voice tenor, or by their own
fatigue. Use of both unfamiliar samples and an
unfamiliar environment significantly limits the
usefulness of this trial in predicts the ability of
DADs. Of additional concern is the lack of
documentation regarding the ongoing training
and reinforcement of skill for the DADs.
There are reports of both success and failure
of DADs, and there have been reports of ‘‘fake’’
service dogs of all types. Clearly, there is a need
for standardized assessment of DADs. The
Penn-Vet group in the U.S. has recently had a
press release stating that they will provide
assessment. We strongly support this group’s
goal of accreditation and would like to see
trainers pass specific certification examinations
before advertising or selling to the public.
Dogs have been well recognized for ability to
help humans due to their keen sense of smell.
The most familiar forms of scent training are
the hunting dog and dogs used to sniff out illicit
drugs. Dogs are also used to sniff out explosives
and other contraband. Recent attention has
been given to dogs as assistance in the medical
field. Dogs have already been used for detection
of cancer [17, 21] and detection of seizures.
Some other medical uses include mobility assist
and guiding blind people. Publications have
also cited the indirect benefit of dogs in
lowering blood pressure and providing stress
relief; as well as encouraging exercise [22]. Each
of these is pertinent benefits for people with
diabetes. Standardization of DAD training and
continued study of their accuracy are needed to
further this important field.
CONCLUSION
Our current study supports evidence that dogs
appear to have full capability to recognize and
alert to Hypo samples from patients with T1D.
More studies are needed to elucidate best practices
for training DADs, and ultimately to identify the
chemical signature that the dogs detect.
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